22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer. (Q40457024)

20 September 2017

22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer. (English)

1 reference

20 September 2017

Kimie Nakagawa

1

1 reference

20 September 2017

Yuko Sasaki

2

1 reference

20 September 2017

Shigeaki Kato

3

1 reference

20 September 2017

Noboru Kubodera

4

1 reference

20 September 2017

Toshio Okano

5

1 reference

20 September 2017

language of work or name

English

0 references

publication date

17 February 2005

1 reference

20 September 2017

1 reference

20 September 2017

26

1 reference

20 September 2017

1044-1054

1 reference

20 September 2017

6

1 reference

A Novel Vitamin D3Analog, 22-Oxa-1, 25- Dihydroxyvitamin D3, Inhibits the Growth of Human Breast Cancerin Vitroandin Vivowithout Causing Hypercalcemia*

20 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI049

1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI049

Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI049

Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI049

Breast cancer metastasis to bone: it is not all about PTHrP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI049

Progress in lung cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI049

EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI049

Differential activities of 1alpha,25-dihydroxy-16-ene-vitamin D(3) analogs and their 3-epimers on human promyelocytic leukemia (HL-60) cell differentiation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI049

Inhibitory effects of 22-oxa-calcitriol and all- trans retinoic acid on the growth of a canine osteosarcoma derived cell-line in vivo and its pulmonary metastasis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI049

Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI049

Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI049

Inhibition of angiogenesis as a mechanism for inhibition by 1alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 of colon carcinogenesis induced by azoxymethane in Wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI049

1,25-Dihydroxyvitamin D3 induces the expression of vascular endothelial growth factor in osteoblastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI049

Prostate cancer cell type-specific regulation of the human PTHrP gene via a negative VDRE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI049

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGI049

1 reference

20 September 2017

1 reference